Egetis Therapeutics AB: European Commission approves Egetis' Emcitate (tiratricol) as the first and only treatment for patients with MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
The Daily Hodl4d
Pantera Capital’s Dan Morehead Says He’s ‘So Bullish’ on Crypto Amid Regulatory Overhaul – Here’s His Forecast
The CEO of investment firm Pantera Capital says he is more bullish than ever on crypto due to the shift in the regulatory ...